Abstract
To investigate whether the presence of infections in C57BL/6 mice influences the metastatic ability of B16 melanoma (B16M) cells, we compared the susceptibility to metastasis development of pathogen-free mice with that of mice from a colony endemically infected with several mouse pathogens. We found that, compared to seronegative controls, mice that were seropositive at least to Mouse Hepatitis Virus (MHV) and Mycoplasma pulmonis: (i) exhibited a higher interindividual variability in all the parameters quantifying metastatic progression; (ii) had elevated serum levels of proinflammatory cytokines both before and at the end of the experiment; (iii) were more susceptible to hepatic metastasis. Interestingly, final levels of tumor necrosis factor (TNF)-α and interleukin (IL)-18 correlated with the extent of hepatic colonization by the melanoma cells. To confirm the metastasis-enhancing effect of MHV and M. pulmonis we measured the ability of B16M cells to metastasize in pathogen-free animals housed for increasing time-intervals in the vicinity of MHV+ animals. Notably, susceptibility to metastasis was lower in animals seronegative to MHV than in MHV+ mice, whereas the latter were less susceptible to metastasis than MHV+ M. pulmonis+ mice. Seropositive animals had increased levels of TNF-α and IL-18 suggesting that MHV and M. pulmonis enhance the metastatic ability of melanoma cells by inducing the release of proinflammatory cytokines. While our results highlight the importance of using pathogen-free animals in metastasis studies, they emphasize the need for a comprehensive health monitoring of the mice used in such studies, particularly in case of using facilities lacking appropriate containment measures.
Keywords: B16 melanoma, C57BL/6 mice, liver metastasis, MHV, murine infections, Mycoplasma pulmonis, proinflammatory cytokines, TNF-α, experimental variability, animal model
Abbreviations
- B16M
B16 melanoma
- ELISA
enzyme-linked immunosorbent assay
- IL-18
interleukin-18
- i.p.
intraperitoneal
- LPS
lipopolysaccharide
- MHV
Mouse Hepatitis Virus
- TNF-α
tumor necrosis factor α
References
- 1.Nicklas W, Homberger FR, Illgen-Wilcke B, et al. Implications of infectious agents on results of animal experiments. Report of the Working Group on Hygiene of the Society for Laboratory Animal Science (SOLAS) Lab Anim. 1999;33(Suppl.1):S1:S39–87. [PubMed] [Google Scholar]
- 2.Baker DG. Future directions in rodent pathogen control. Ilar J. 1998;39(4):312–15. doi: 10.1093/ilar.39.4.312. [DOI] [PubMed] [Google Scholar]
- 3.Lussier G. Potential detrimental effects of rodent viral infections on long-term experiments. Vet Res Commun. 1988;12(2–3):199–217. doi: 10.1007/BF00362802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Einarsson O, Geba GP, Zhu Z, et al. Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest. 1996;97(4):915–24. doi: 10.1172/JCI118514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Howard Control of variability. Ilar J. 2002;43(4):194–201. doi: 10.1093/ilar.43.4.194. [DOI] [PubMed] [Google Scholar]
- 6.Zenner L, Regnault JP. Ten-year long monitoring of laboratory mouse and rat colonies in French facilities: A retrospective study. Lab Anim. 2000;34(1):76–83. doi: 10.1258/002367700780577957. [DOI] [PubMed] [Google Scholar]
- 7.Baker DG. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev. 1998;11(2):231–66. doi: 10.1128/cmr.11.2.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hansen AK. New infections to be considered in health monitoring of laboratory rodents. Scand J Lab Anim Sci. 2000;27(2):65–83. [Google Scholar]
- 9.Weisbroth SH, Peters R, Riley LK, et al. Microbiological assessment of laboratory rats and mice. Ilar J. 1998;39(4):272–90. doi: 10.1093/ilar.39.4.272. [DOI] [PubMed] [Google Scholar]
- 10.Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36(1):20–42. doi: 10.1258/0023677021911740. [DOI] [PubMed] [Google Scholar]
- 11.National Research Council . Infections Diseases of Mice and Rats: A Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. Washington, DC: National Academy Press; 1991. [Google Scholar]
- 12.Vidal-Vanaclocha F, Amezaga C, Asumendi A, et al. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res. 1994;54(10):2667–72. [PubMed] [Google Scholar]
- 13.Vidal-Vanaclocha F, Alvarez A, Asumendi A, et al. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst. 1996;88(3–4):198–205. doi: 10.1093/jnci/88.3-4.198. [DOI] [PubMed] [Google Scholar]
- 14.Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci USA. 2000;97(2):734–9. doi: 10.1073/pnas.97.2.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Carrascal MT, Mendoza L, Valcarcel M, et al. Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res. 2003;63(2):491–7. [PubMed] [Google Scholar]
- 16.Stohlman SA, Yao Q, Bergmann CC, et al. Transcription and translation of proinflammatory cytokines following JHMV infection. In: Talbot PJ, et al., editors. Corona and Related Viruses. New York: Plenum Press; 1995. pp. 173–8. [DOI] [PubMed] [Google Scholar]
- 17.Stohlman SA, Hinton DR, Cua D, et al. Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J Virol. 1995;69(9):5898–903. doi: 10.1128/jvi.69.9.5898-5903.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. Am Assoc Immunol. 1998;65:3487–93. [PubMed] [Google Scholar]
- 19.Homberger FR. Enterotropic mouse hepatitis virus. Lab Anim. 1997;31(2):97–115. doi: 10.1258/002367797780600189. [DOI] [PubMed] [Google Scholar]
- 20.Homberger FR, Zhang L, Barthold SW. Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci. 1998;48(1):50–54. [PubMed] [Google Scholar]
- 21.Lai WC, Bennett M, Pakes SP, et al. Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. J Infect Dis. 1990;161(6):1269–75. doi: 10.1093/infdis/161.6.1269. [DOI] [PubMed] [Google Scholar]
- 22.Smith AL, Barthold SW, de Souza MS, et al. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol. 1991;121(1–4):89–100. doi: 10.1007/BF01316746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cartner SC, Simecka JW, Lindsey JR, et al. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: Lesion severity and antibody response. Infect Immun. 1995;63(10):4138–42. doi: 10.1128/iai.63.10.4138-4142.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Festing MF. The design and statistical analysis of animal experiments. Ilar J. 2002;43(4):191–3. doi: 10.1093/ilar.43.4.191. [DOI] [PubMed] [Google Scholar]